It is a pharma private limited company based in Jalgaon, Maharashtra, India, established in 1974.
1974 | Jalgaon, Maharashtra, India | ActivePolymed Pharmaceuticals Private Limited, a active private limited company, was established on 05 April 1974 in Jalgaon, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U99999MH1974PTC017372. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Suvarna Sumit Kabra (Director), Sunit Kedarnath Kabra (Director), Kausalya Kedarnath Kabra (Director). Past directors included Kedarnath Bhaulal Kabray, Sumit Kedarnath Kabra. It holds ₹5.00 M open charges and ₹1.63 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 12-A, Industrial Estate,Ajantha Road, Jalgaon., Jalgaon, Maharashtra.
U99999MH1974PTC017372
017372
05 April 1974
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Polymed Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suvarna Sumit Kabra | Director | 29 Sep 2000 | Current |
| Sunit Kedarnath Kabra | Director | 29 Sep 2000 | Current |
| Kausalya Kedarnath Kabra | Director | 05 Apr 1974 | Current |
| Sumit Kedarnath Kabra | Director | 29 Sep 2000 | Current |
| Mamta Sunit Kabra | Director | 29 Sep 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 18 Mar 2011 | Past |
| Pramod Abcsdd | Company Secretary | 02 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Polymed Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.31% decrease. The company also saw a substantial fall in profitability, with a 88.2% decrease in profit. The company's net worth moved up by a moderate rise of 3.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Polymed Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹1,630,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 2016 | Others | ₹5.00 M | Open |
| 13 May 2016 | Others | ₹0.90 M | Satisfied |
| 25 Mar 2009 | The Akola Urban Co.-Op. Bank Ltd. | ₹0.45 M | Satisfied |
| 04 Oct 1978 | Bank Of Baroda | ₹0.15 M | Satisfied |
| 20 Jul 1976 | Bank Of Baroda | ₹0.14 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Polymed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Polymed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Polymed Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Polymed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Polymed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Progress on A charge with Others of Rs. 5.00 M registered on 13 May 2016 with Charge ID 100032553 was modified on 14 Jun 2023. was documented.
The activity A charge registered on 13 May 2016 via Charge ID 100032554 with Others was fully satisfied on 18 May 2021. was completed.
Progress on A charge with Others amounted to Rs. 0.90 M with Charge ID 100032554 was registered on 13 May 2016. was documented.
A charge with Others amounted to Rs. 5.00 M with Charge ID 100032553 was registered on 13 May 2016. was recorded as a recent event.
The CIN of Polymed Pharmaceuticals Private Limited is U99999MH1974PTC017372.
Polymed Pharmaceuticals Private Limited is headquartered at 12-A, Industrial Estate,Ajantha Road, Jalgaon., Jalgaon, Maharashtra.
Polymed Pharmaceuticals Private Limited was incorporated on 05 April 1974.
The current directors of Polymed Pharmaceuticals Private Limited are
The primary industry of Polymed Pharmaceuticals Private Limited is Manufacturing.
Polymed Pharmaceuticals Private Limited is unlisted.
The authorized capital of Polymed Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Polymed Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX